Cdk5: mediator of neuronal development, death and the response to DNA damage

Jinqiu Zhu1, Wenming Li, Zixu Mao

  • 1Department of Pharmacology, Emory University School of Medicine, Whitehead Bldg., Rm505L 615 Michael St., Atlanta, GA 30322, USA.

Insights

Cyclin-dependent kinase 5 (Cdk5) regulates brain functions. Its dysregulation contributes to neurodegenerative diseases, particularly neuronal death linked to DNA damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin-dependent kinase 5 (Cdk5) is crucial for central nervous system physiological processes.
  • Cdk5 dysregulation is linked to neurodegenerative disease pathogenesis.
  • DNA damage is increasingly recognized as a factor in neurodegeneration.

Purpose of the Study:

  • To review the regulation and roles of Cdk5 in physiological conditions.
  • To discuss Cdk5 dysregulation in pathological conditions, focusing on DNA damage-induced neuronal death.

Main Methods:

  • Literature review of recent research on Cdk5.
  • Analysis of Cdk5's role in neuronal survival, migration, differentiation, synaptogenesis, plasticity, and neurotransmission.
  • Examination of Cdk5's involvement in DNA damage pathways and neurodegeneration.

Main Results:

  • Cdk5 plays diverse roles in normal brain function.
  • Aberrant Cdk5 activity is implicated in the progression of neurodegenerative disorders.
  • Cdk5 mediates neuronal death pathways associated with DNA damage.

Conclusions:

  • Cdk5 is a key regulator in the CNS with implications for neurodegenerative diseases.
  • Understanding Cdk5's role in DNA damage is critical for developing therapeutic strategies for neurodegeneration.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...